You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic antibody-mediated rejection,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transplant Glomerulopathy Trial in Birmingham, Baltimore (Acthar gel)

Terminated
Has Results
  • Transplant Glomerulopathy
  • Acthar gel
  • Birmingham, Alabama
  • +1 more
Oct 3, 2022

Donor-Derived Cell-Free DNA With Tocilizumab Treatment for

Active, not recruiting
  • Rejection Chronic Renal
  • Kidney Transplant Rejection
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jul 18, 2022

    Antibody-mediated Rejection Trial in Gothenburg, Stockholm, Uppsala (Tocilizumab)

    Recruiting
    • Antibody-mediated Rejection
    • Gothenburg, Vastra Gotaland Regioin, Sweden
    • +2 more
    Feb 16, 2022

    Assess Burden of Disease Among Kidney Transplant Recipients With

    Recruiting
    • Antibody-mediated Rejection in Kidney Transplant
    • Chronic active AMR group
    • Non-Chronic active AMR group
    • Cardiff, United Kingdom
    • +4 more
    Aug 2, 2022

    Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

    Active, not recruiting
    • Antibody-mediated Rejection
    • +5 more
    • Los Angeles, California
      Norko Ammerman
    Mar 25, 2022

    Approach on Kidney Transplant Recipients With Antibody-Mediated

    Completed
    • Antibody-mediated Rejection
    • +2 more
      • Istanbul, Turkey
        Istanbul University
      May 16, 2021

      Kidney Transplantation Trial (Extracorporeal phototherapy)

      Not yet recruiting
      • Kidney Transplantation
      • Extracorporeal phototherapy
      • (no location specified)
      Apr 28, 2021

      Renal Transplant Rejection Trial in London (Fostamatinib)

      Recruiting
      • Renal Transplant Rejection
      • London, United Kingdom
        Imperial College NHS Healthcare Trust
      Oct 1, 2021

      Trial of Kidney Tx Patients Treated With Imlifidase or PE

      Recruiting
      • Kidney Transplant Rejection
      • Vienna, Austria
      • +4 more
      Apr 7, 2022

      Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

      Active, not recruiting
      • Kidney Failure, Chronic
      • +6 more
      • Los Angeles, California
        Norko Ammerman
      Mar 25, 2022

      Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

      Recruiting
      • Antibody-mediated Rejection
      • Vienna, Austria
      • +1 more
      Aug 23, 2022

      Kidney Transplant Rejection, Antibody-mediated Rejection, Kidney Transplant Failure Trial in Berlin (Kidney allograft biopsy

      Active, not recruiting
      • Kidney Transplant Rejection
      • +2 more
      • Kidney allograft biopsy depending on donor-derived cell-free DNA levels
      • Berlin, Germany
        Charité-Universitätsmedizin
      Jul 22, 2022

      Subclass of Donor-specific Antibody asRisk Factor of Antibody

      Active, not recruiting
      • Antibody-mediated Rejection
        • Montpellier, Hérault, France
          CHU Lapeyronie
        Jan 18, 2023

        Antibody-mediated Rejection, Lung Transplant Rejection Trial (Extracorporeal Photopheresis)

        Not yet recruiting
        • Antibody-mediated Rejection
        • Lung Transplant Rejection
        • Extracorporeal Photopheresis
        • (no location specified)
        Oct 30, 2023

        Antibody Mediated Processes After Kidney Transplantation

        Recruiting
        • Kidney Transplant Failure and Rejection
        • AlloSure ddcfDNA assay
        • +3 more
        • Madison, Wisconsin
          University of Wisconsin - Madison
        Aug 16, 2022

        Antibody-mediated Rejection, Kidney Tranplant Trial in Hangzhou (Daratumumab)

        Not yet recruiting
        • Antibody-mediated Rejection
        • Kidney Tranplant
        • Hangzhou, Zhejiang, China
          79# Qingchun Road
        Jun 21, 2023

        Donor Specific B Cells and Antibody Mediated Rejection

        Terminated
        • Sensitized Kidney Transplant Recipients
          • Madison, Wisconsin
            University of Wisconsin Hospital and Clinics
          Dec 13, 2021

          Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

          Not yet recruiting
          • Antibody-mediated Rejection
          • Allosensitization
          • New York, New York
            NYU Langone Health
          May 16, 2023

          Chronic Antibody-mediated Transplant Rejection Trial in Paris (Bortezomib, Plasma exchanges and intravenous immunoglobulins)

          Completed
          • Chronic Antibody-mediated Transplant Rejection
          • Bortezomib
          • Plasma exchanges and intravenous immunoglobulins
          • Paris, France
            Hopital Necker Enfants-malades
          Sep 14, 2020

          ABO Blood Type Incompatible Kidney Transplantation, Antibody-mediated Rejection Trial in Seoul (5-gene classification model)

          Active, not recruiting
          • ABO Blood Type Incompatible Kidney Transplantation
          • Antibody-mediated Rejection
          • 5-gene classification model
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Oct 24, 2022

          ddcfDNA in Kidney Transplant Recipients

          Recruiting
          • Kidney Transplant Rejection
          • AlloSeq cfDNA
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Aug 22, 2023

          Antibody-mediated Rejection Trial in Tehran (Bortezomib)

          Recruiting
          • Antibody-mediated Rejection
          • Tehran, Iran, Islamic Republic of
            SBMU
          Jan 27, 2022

          Kidney Transplantation, Kidney Transplant Rejection Trial in Guangzhou

          Not yet recruiting
          • Kidney Transplantation
          • Kidney Transplant Rejection
            • Guangzhou, Guangdong, China
              The First Affiliated Hospital, Sun Yat-sen University
            Mar 19, 2023

            MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart

            Active, not recruiting
            • Transplant Failure
            • +2 more
            • Echocardiogram
            • +3 more
            • Majadahonda, Madrid, Spain
            • +2 more
            Jun 14, 2022

            Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

            Enrolling by invitation
            • Antibody-mediated Rejection
            • Cardiac Transplant
            • Daratumumab and hyaluronidase-fihj
            • Rochester, Minnesota
              Mayo Clinic Rochester
            Apr 11, 2022